MRP3 expression did not vary significantly with age (P>0.9999) but showed significant differences with menopausal status, tumor size, histology, clinical stage, lymph node metastasis, PR status, and BRCA2 status. This evidence concerns the gene ABCC3 and metastatic malignant neoplasm in the lymph nodes.